Cleaning validation is a regulatory requirement for any pharmaceutical manufacturing equipment that is shared between products or between batches of the same product. Its purpose is to demonstrate that your cleaning procedure reliably removes product residues, cleaning agents, and microbial contamination to levels that will not affect the safety, quality, or efficacy of the next product manufactured on that equipment.
The most technically demanding aspect of cleaning validation is establishing and justifying the acceptance criteria - the maximum allowable residue levels. This guide explains the regulatory basis for cleaning acceptance criteria, how to calculate MACO, and the practical considerations for choosing between rinse and swab sampling.
Regulatory Basis for Cleaning Validation
EU GMP Annex 15 (2015 revision) provides the most detailed regulatory guidance on cleaning validation in the European context. It requires that cleaning validation studies demonstrate removal of product residues, cleaning agents, and microbial contamination. The FDA's Guide to Inspections of Validation of Cleaning Processes (1993, still current) and the EMA's Guideline on Setting Health-Based Exposure Limits (2014) provide additional technical frameworks.
What Is MACO?
MACO stands for Maximum Allowable Carryover - the maximum amount of a previous product (the "donor product") that is allowed to carry over into the next product (the "recipient product") manufactured on the same equipment.
The traditional MACO calculation uses the lowest of three limits:
- The therapeutic dose limit - 0.1% of the minimum therapeutic daily dose of the donor product in the maximum daily dose of the recipient product
- The 10 ppm limit - the donor product concentration in the recipient product must not exceed 10 parts per million (10 mg/kg)
- The visual limit - no visible residue should remain on equipment surfaces after cleaning
The MACO is the most stringent of these three values - the calculation that results in the lowest permitted carryover.
Health-Based Exposure Limits (HBELs). The EMA's 2014 guideline introduced the concept of health-based exposure limits, calculated from toxicological data (PDE - Permitted Daily Exposure). For highly potent or toxic active substances, the HBEL-based MACO is more stringent than the traditional 0.1% dose and 10 ppm limits. HBEL-based acceptance criteria are now expected for all new cleaning validation studies in Europe.
MACO Calculation: Step by Step
The traditional therapeutic dose-based MACO formula is:
MACO = (TDmin × SF) / LDD
Where:
- TDmin = the minimum therapeutic daily dose of the donor product
- SF = safety factor (typically 1/1000 to give 0.001 × TDmin)
- LDD = the largest daily dose of the recipient product
The result gives the maximum mass of donor product that may appear in one day's dose of the recipient product.
To convert MACO to a surface residue limit (for swab sampling):
Limit (µg/cm²) = MACO / (BSA × SSA)
Where BSA is the batch size of the recipient product and SSA is the shared surface area of the equipment.
Rinse Sampling vs Swab Sampling
The two primary sampling methods for cleaning validation are rinse sampling and swab sampling. Most cleaning validation programmes use both in combination:
- Rinse sampling - collecting a final rinse sample from the equipment after cleaning and analysing it for residue. Advantages: samples the entire equipment surface; easy to perform. Disadvantages: dilution effect makes detection of low-level residues difficult; does not distinguish between surfaces that are easy vs. difficult to clean.
- Swab sampling - physically swabbing defined surface areas using a wetted swab and analysing the swab for residue. Advantages: direct surface measurement; identifies difficult-to-clean "worst case" locations; more sensitive than rinse sampling for most analytes. Disadvantages: requires validation of swab recovery efficiency; more labour-intensive; swab recovery varies by surface material.
Regulatory expectation (reflected in EMA and FDA guidance) is that swab sampling is preferred for cleaning validation because it provides direct surface measurement. Rinse sampling alone is generally not acceptable for equipment validation unless it can be justified that all surfaces are equally accessible and rinseable.
Worst-Case Product Selection
Cleaning validation studies are not required for every product manufactured on each piece of equipment - a bracketing or matrix approach using worst-case products is acceptable. Worst-case selection considers:
- Products with the lowest therapeutic dose (most potent) - set the most stringent MACO
- Products with the most difficult-to-clean active ingredients (sticky, poorly soluble, or highly coloured)
- Products with the lowest batch size manufactured on the equipment (least dilution of carry-over)
- Equipment with the most complex geometry or hardest-to-reach surfaces
Demonstrating cleaning validation for the worst-case product validates the cleaning procedure for all other products in the "family" - provided the cleaning procedure is the same and the products are of similar category.
Free Cleaning Validation MACO Calculator Template
Download our spreadsheet template for MACO calculation - including therapeutic dose method, 10 ppm method, and HBEL comparison, pre-formatted for regulatory documentation.
Download Free Checklist →